JOHNSON & JOHNSON Insider Trading Transactions
Get free email notifications about insider trading for JOHNSON & JOHNSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHNSON & JOHNSON. JOHNSON & JOHNSON is 10% Owner in JOHNSON & JOHNSON ($JNJ) and 10% Owner in BARRIER THERAPEUTICS INC ($BTRX) and 10% Owner in CORNERSTONE THERAPEUTICS INC ($CRTX) and 10% Owner in IMMUNICON CORP ($IMMC) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in TENGION INC ($TNGN) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in Protagonist Therapeutics, Inc ($PTGX) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and 10% Owner in NEVRO CORP ($NVRO) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Minerva Neurosciences, Inc. ($NERV) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and 10% Owner in Provention Bio, Inc. ($PRVB) and 10% Owner in Fusion Pharmaceuticals Inc. ($FUSN).
Latest Insider Trading Transactions of JOHNSON & JOHNSON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, ALDX, BTRX, CRTX, FUSN, GNCA, IMMC, INSP, JNJ, NERV, NLTX, NVRO, PTGX, PRVB, TNGN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 89,118 | 0 | 89,118 | |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 475,802 | 0 | 0 | |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 5,059,460 | 0 | 0 | |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 17.00 | 725,000 | 12,325,000 | 3,670,516 | 2.9 M to 3.7 M (+24.61 %) |
Jul 02 2020 | FUSN | Fusion Pharmaceuti ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 2,945,516 | 0 | 2,945,516 | 0 to 2.9 M |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 89,118 | 0 | 89,118 | |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 475,802 | 0 | 0 | |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 5,059,460 | 0 | 0 | |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | P | 17.00 | 725,000 | 12,325,000 | 3,670,516 | 2.9 M to 3.7 M (+24.61 %) |
Jul 02 2020 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 2,945,516 | 0 | 2,945,516 | 0 to 2.9 M |
Jul 20 2018 | PRVB | Provention Bio, In ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
Jul 20 2018 | PRVB | Provention Bio, In ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 2,400,000 | 0 | 2,400,000 | 0 to 2.4 M |
Jul 20 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
Jul 20 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 2,400,000 | 0 | 2,400,000 | 0 to 2.4 M |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 248,631 | 0 | 0 | |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 1,145,038 | 0 | 0 | |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 37,388 | 0 | 235,251 | 197.9 K to 235.3 K (+18.90 %) |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 197,863 | 0 | 197,863 | 0 to 197.9 K |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 248,631 | 0 | 0 | |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 1,145,038 | 0 | 0 | |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 37,388 | 0 | 235,251 | 197.9 K to 235.3 K (+18.90 %) |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 197,863 | 0 | 197,863 | 0 to 197.9 K |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 248,631 | 0 | 0 | |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 1,145,038 | 0 | 0 | |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 37,388 | 0 | 235,251 | 197.9 K to 235.3 K (+18.90 %) |
May 07 2018 | INSP | Inspire Medical Sy ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 197,863 | 0 | 197,863 | 0 to 197.9 K |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 248,631 | 0 | 0 | |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 1,145,038 | 0 | 0 | |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 37,388 | 0 | 235,251 | 197.9 K to 235.3 K (+18.90 %) |
May 07 2018 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 197,863 | 0 | 197,863 | 0 to 197.9 K |
Nov 22 2017 | ACHN | ACHILLION PHARMACE ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 2.75 | 18,367,346 | 50,510,202 | 0 | 18.4 M to 0 (-100.00 %) |
Nov 22 2017 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Sell | S | 2.75 | 18,367,346 | 50,510,202 | 0 | 18.4 M to 0 (-100.00 %) |
Sep 14 2017 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Sell | J | 0.00 | 3,892,256 | 389 | 0 | 3.9 M to 0 (-100.00 %) |
Sep 14 2017 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Sell | J | 0.00 | 3,892,256 | 389 | 0 | 3.9 M to 0 (-100.00 %) |
Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 13,054,830 | 0 | 0 | |
Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 14,000,000 | 0 | 0 | |
Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,449,183 | 1.9 M to 2.4 M (+31.26 %) |
Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 900,333 | 0 | 1,865,850 | 965.5 K to 1.9 M (+93.25 %) |
Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 965,517 | 0 | 965,517 | 0 to 965.5 K |
Aug 18 2016 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 13,054,830 | 0 | 0 | |
Aug 18 2016 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 14,000,000 | 0 | 0 | |
Aug 18 2016 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,449,183 | 1.9 M to 2.4 M (+31.26 %) |
Aug 18 2016 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 900,333 | 0 | 1,865,850 | 965.5 K to 1.9 M (+93.25 %) |
Aug 18 2016 | JNJ | JOHNSON & JOHNSON | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 965,517 | 0 | 965,517 | 0 to 965.5 K |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 20.74 | 1,283,366 | 26,617,011 | 100,000 | 1.4 M to 100 K (-92.77 %) |
Aug 12 2015 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 31.66 | 231,455 | 7,327,865 | 1,383,366 | 1.6 M to 1.4 M (-14.33 %) |
Aug 12 2015 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 20.74 | 1,283,366 | 26,617,011 | 100,000 | 1.4 M to 100 K (-92.77 %) |
Aug 12 2015 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 31.66 | 231,455 | 7,327,865 | 1,383,366 | 1.6 M to 1.4 M (-14.33 %) |
Jun 08 2015 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Sell | S | 47.94 | 1,010,265 | 48,432,104 | 2,066,740 | 3.1 M to 2.1 M (-32.83 %) |
Jun 08 2015 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 47.94 | 1,010,265 | 48,432,104 | 2,066,740 | 3.1 M to 2.1 M (-32.83 %) |
Mar 17 2015 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | P | 5.77 | 607,903 | 3,508,816 | 607,903 | |
Mar 17 2015 | NERV | Minerva Neuroscien ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 4.81 | 607,903 | 2,924,013 | 4,500,159 | 3.9 M to 4.5 M (+15.62 %) |
Mar 17 2015 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | P | 5.77 | 607,903 | 3,508,816 | 607,903 | |
Mar 17 2015 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 4.81 | 607,903 | 2,924,013 | 4,500,159 | 3.9 M to 4.5 M (+15.62 %) |
Dec 18 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.58 | 1,593 | 12,075 | 1,342,094 | 1.3 M to 1.3 M (-0.12 %) |
Dec 18 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.63 | 6,507 | 49,648 | 1,343,687 | 1.4 M to 1.3 M (-0.48 %) |
Dec 18 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.58 | 1,593 | 12,075 | 1,342,094 | 1.3 M to 1.3 M (-0.12 %) |
Dec 18 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.63 | 6,507 | 49,648 | 1,343,687 | 1.4 M to 1.3 M (-0.48 %) |
Dec 15 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.51 | 3,645 | 27,374 | 1,350,194 | 1.4 M to 1.4 M (-0.27 %) |
Dec 15 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.50 | 1,355 | 10,163 | 1,353,839 | 1.4 M to 1.4 M (-0.10 %) |
Dec 15 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.51 | 3,645 | 27,374 | 1,350,194 | 1.4 M to 1.4 M (-0.27 %) |
Dec 15 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.50 | 1,355 | 10,163 | 1,353,839 | 1.4 M to 1.4 M (-0.10 %) |
Dec 10 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.70 | 1,300 | 10,010 | 1,355,194 | 1.4 M to 1.4 M (-0.10 %) |
Dec 10 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.73 | 5,000 | 38,650 | 1,356,494 | 1.4 M to 1.4 M (-0.37 %) |
Dec 10 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.69 | 2,000 | 15,380 | 1,361,494 | 1.4 M to 1.4 M (-0.15 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.70 | 1,300 | 10,010 | 1,355,194 | 1.4 M to 1.4 M (-0.10 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.73 | 5,000 | 38,650 | 1,356,494 | 1.4 M to 1.4 M (-0.37 %) |
Dec 10 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.69 | 2,000 | 15,380 | 1,361,494 | 1.4 M to 1.4 M (-0.15 %) |
Dec 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.78 | 4,200 | 32,676 | 1,363,494 | 1.4 M to 1.4 M (-0.31 %) |
Dec 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.76 | 10,073 | 78,166 | 1,367,694 | 1.4 M to 1.4 M (-0.73 %) |
Dec 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.75 | 1,627 | 12,609 | 1,377,767 | 1.4 M to 1.4 M (-0.12 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.78 | 4,200 | 32,676 | 1,363,494 | 1.4 M to 1.4 M (-0.31 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.76 | 10,073 | 78,166 | 1,367,694 | 1.4 M to 1.4 M (-0.73 %) |
Dec 05 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.75 | 1,627 | 12,609 | 1,377,767 | 1.4 M to 1.4 M (-0.12 %) |
Dec 03 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.54 | 1,200 | 9,048 | 1,379,394 | 1.4 M to 1.4 M (-0.09 %) |
Dec 03 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.54 | 1,200 | 9,048 | 1,379,394 | 1.4 M to 1.4 M (-0.09 %) |
Nov 26 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.60 | 500 | 3,800 | 1,380,594 | 1.4 M to 1.4 M (-0.04 %) |
Nov 26 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.80 | 1,500 | 11,700 | 1,381,094 | 1.4 M to 1.4 M (-0.11 %) |
Nov 26 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.60 | 500 | 3,800 | 1,380,594 | 1.4 M to 1.4 M (-0.04 %) |
Nov 26 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 7.80 | 1,500 | 11,700 | 1,381,094 | 1.4 M to 1.4 M (-0.11 %) |
Nov 24 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.02 | 4,000 | 32,080 | 1,382,594 | 1.4 M to 1.4 M (-0.29 %) |
Nov 24 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.25 | 2,400 | 19,800 | 1,386,594 | 1.4 M to 1.4 M (-0.17 %) |
Nov 24 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.21 | 3,100 | 25,451 | 1,388,994 | 1.4 M to 1.4 M (-0.22 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.02 | 4,000 | 32,080 | 1,382,594 | 1.4 M to 1.4 M (-0.29 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.25 | 2,400 | 19,800 | 1,386,594 | 1.4 M to 1.4 M (-0.17 %) |
Nov 24 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 8.21 | 3,100 | 25,451 | 1,388,994 | 1.4 M to 1.4 M (-0.22 %) |
Nov 12 2014 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 246,827 | 0 | 0 | |
Nov 12 2014 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,790,178 | 0 | 0 | |
Nov 12 2014 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Buy | P | 18.00 | 40,000 | 720,000 | 3,077,005 | 3 M to 3.1 M (+1.32 %) |
Nov 12 2014 | NVRO | NEVRO CORP | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 3,037,005 | 0 | 3,037,005 | 0 to 3 M |
Nov 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 246,827 | 0 | 0 | |
Nov 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,790,178 | 0 | 0 | |
Nov 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 18.00 | 40,000 | 720,000 | 3,077,005 | 3 M to 3.1 M (+1.32 %) |
Nov 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 3,037,005 | 0 | 3,037,005 | 0 to 3 M |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | M | 5.16 | 36,345 | 187,540 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | M | 5.16 | 36,345 | 187,540 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 133,827 | 0 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 427,591 | 0 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 104,396 | 0 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 385,800 | 0 | 0 | |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Payment of Exercise | F | 8.00 | 23,438 | 187,504 | 1,750,292 | 1.8 M to 1.8 M (-1.32 %) |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | M | 5.16 | 36,345 | 187,540 | 1,773,730 | 1.7 M to 1.8 M (+2.09 %) |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Payment of Exercise | F | 8.00 | 23,438 | 187,504 | 1,737,385 | 1.8 M to 1.7 M (-1.33 %) |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | M | 5.16 | 36,345 | 187,540 | 1,760,823 | 1.7 M to 1.8 M (+2.11 %) |
May 05 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,724,478 | 0 | 1,724,478 | 0 to 1.7 M |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | M | 5.16 | 36,345 | 187,540 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | M | 5.16 | 36,345 | 187,540 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 133,827 | 0 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 427,591 | 0 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 104,396 | 0 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 385,800 | 0 | 0 | |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Payment of Exercise | F | 8.00 | 23,438 | 187,504 | 1,750,292 | 1.8 M to 1.8 M (-1.32 %) |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Buy | M | 5.16 | 36,345 | 187,540 | 1,773,730 | 1.7 M to 1.8 M (+2.09 %) |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Payment of Exercise | F | 8.00 | 23,438 | 187,504 | 1,737,385 | 1.8 M to 1.7 M (-1.33 %) |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Buy | M | 5.16 | 36,345 | 187,540 | 1,760,823 | 1.7 M to 1.8 M (+2.11 %) |
May 05 2014 | ALDX | Aldeyra Therapeuti ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,724,478 | 0 | 1,724,478 | 0 to 1.7 M |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 379,543 | 0 | 0 | |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 292,532 | 0 | 0 | |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 293,884 | 0 | 0 | |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 170,454 | 0 | 0 | |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 255,681 | 0 | 0 | |
Mar 12 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,392,094 | 0 | 1,392,094 | 0 to 1.4 M |
Feb 11 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 351,866 | 0 | 0 | |
Feb 11 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 827,917 | 0 | 0 | |
Feb 11 2014 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,388,645 | 0 | 1,388,645 | 0 to 1.4 M |
Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 351,866 | 0 | 0 | |
Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 827,917 | 0 | 0 | |
Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,388,645 | 0 | 1,388,645 | 0 to 1.4 M |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 379,543 | 0 | 0 | |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 292,532 | 0 | 0 | |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 293,884 | 0 | 0 | |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 170,454 | 0 | 0 | |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 255,681 | 0 | 0 | |
Mar 12 2014 | AQXP | AQUINOX PHARMACEUT ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,392,094 | 0 | 1,392,094 | 0 to 1.4 M |
Apr 14 2010 | TNGN | TENGION INC | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 3,823,817 | 0 | 0 | |
Apr 14 2010 | TNGN | TENGION INC | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,162,818 | 0 | 0 | |
Apr 14 2010 | TNGN | TENGION INC | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 4,961,653 | 0 | 0 | |
Apr 14 2010 | TNGN | TENGION INC | JOHNSON & JOHNSON | 10% Owner | Buy | P | 5.00 | 400,000 | 2,000,000 | 1,194,654 | 794.7 K to 1.2 M (+50.34 %) |
Apr 14 2010 | TNGN | TENGION INC | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 755,053 | 0 | 794,654 | 39.6 K to 794.7 K (+1,906.65 %) |
Apr 14 2010 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 3,823,817 | 0 | 0 | |
Apr 14 2010 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 2,162,818 | 0 | 0 | |
Apr 14 2010 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 4,961,653 | 0 | 0 | |
Apr 14 2010 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 5.00 | 400,000 | 2,000,000 | 1,194,654 | 794.7 K to 1.2 M (+50.34 %) |
Apr 14 2010 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 755,053 | 0 | 794,654 | 39.6 K to 794.7 K (+1,906.65 %) |
Feb 15 2005 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 19.50 | 694,327 | 13,539,377 | 3,753,749 | 4.4 M to 3.8 M (-15.61 %) |
Feb 15 2005 | BTRX | BARRIER THERAPEUTI ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 19.50 | 694,327 | 13,539,377 | 3,753,749 | 4.4 M to 3.8 M (-15.61 %) |
Jun 14 2004 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | X | 2.40 | 2,667 | 6,401 | 0 | |
Jun 14 2004 | JNJ | JOHNSON & JOHN ... | JOHNSON & JOHNSON | 10% Owner | Buy | X | 2.40 | 2,667 | 6,401 | 1,771,571 | 1.8 M to 1.8 M (+0.15 %) |